DNA repair activity may be associated with risk of lung cancer

September 02, 2003

People with reduced DNA repair activity, as determined by a blood test, appear to be at a higher risk of developing lung cancer than people with average DNA repair activity, according to a study in the September 3 issue of the Journal of the National Cancer Institute. The findings suggest a genetic predisposition to lung cancer in some individuals and may explain why only a fraction of smokers develop the disease.

Tobacco smoke contains many carcinogens that are known to damage DNA. Reduced ability to repair damaged DNA has been associated with a predisposition to lung cancer in previous studies. To examine the association between a specific DNA repair enzyme and risk of lung cancer, Zvi Livneh, Ph.D., and Tamar Paz-Elizur, Ph.D., of the Weizmann Institute of Science in Rehovot, Israel, and their colleagues measured the activity of the DNA repair enzyme OGG in blood samples of 68 patients with non-small-cell lung cancer and 68 healthy people.

OGG activity was statistically significantly lower in lung cancer patients than in controls and was the same in smokers and non-smokers. After adjusting for age and smoking status, people in the bottom third of OGG activity had 4.8 times the risk of lung cancer as people in the top third of OGG activity.

In addition, the authors found that smoking and low OGG activity were independent risk factors for lung cancer and that people who smoked and had low OGG activity had the greatest risk of lung cancer. Whereas nonsmokers with very low OGG activity had seven times the lung cancer risk of nonsmokers with normal OGG activity, smokers with low OGG activity were more than 100 times the risk of lung cancer of smokers with normal OGG.

The findings suggest that "a substantial fraction of lung cancer cases might result from a combination of smoking and reduced OGG activity," the authors write. "If so, then screening for smokers with low OGG activity, followed by smoking cessation in these individuals, may lead to a decrease in the incidence of lung cancer."

In an accompanying editorial, Neil Caporaso, M.D., of the National Cancer Institute, says that it will be important to examine in greater detail whether OGG activity is influenced by exposures (for example, among never, former, and current smokers) and disease (for example, in treated and untreated subjects and by histology and stage).

He concludes that integrated large studies will help establish the role of oxidative repair phenotypes in human disease and cancer. "Regardless of how refined a picture emerges from human and animal models, large-scale work in human populations will be required to confirm effects in realistic settings and to gauge public health implications," he writes.
Contact: Zvi Livneh, Weizmann Institute of Science, 972-54-774-637 or 972-8-934-3203 (no later than 5pm ET or midnight GMT) zvi.livneh@weizmann.ac.il.

Editorial: NCI Press Office, 301-496-6641, ncipressofficers@mail.nih.gov.

Paz-Elizur T, Krupsky M, Blumenstein S, Elinger D, Schechtman E, Livneh Z. DNA repair activity for oxidative damage and risk of lung cancer. J Natl Cancer Inst 2003;95:1312-19.

Editorial: Caporaso N. The molecular epidemiology of oxidative damage to DNA and cancer. J Natl Cancer Inst 2003;95:1263-65.

Note: The Journal of the National Cancer Institute is published by Oxford University Press and is not affiliated with the National Cancer Institute. Attribution to the Journal of the National Cancer Institute is requested in all news coverage.

Journal of the National Cancer Institute

Related Lung Cancer Articles from Brightsurf:

State-level lung cancer screening rates not aligned with lung cancer burden in the US
A new study reports that state-level lung cancer screening rates were not aligned with lung cancer burden.

The lung microbiome may affect lung cancer pathogenesis and prognosis
Enrichment of the lungs with oral commensal microbes was associated with advanced stage disease, worse prognosis, and tumor progression in patients with lung cancer, according to results from a study published in Cancer Discovery, a journal of the American Association for Cancer Research.

New analysis finds lung cancer screening reduces rates of lung cancer-specific death
Low-dose CT screening methods may prevent one death per 250 at-risk adults screened, according to a meta-analysis of eight randomized controlled clinical trials of lung cancer screening.

'Social smokers' face disproportionate risk of death from lung disease and lung cancer
'Social smokers' are more than twice as likely to die of lung disease and more than eight times as likely to die of lung cancer than non-smokers, according to research presented at the European Respiratory Society International Congress.

Lung cancer therapy may improve outcomes of metastatic brain cancer
A medication commonly used to treat non-small cell lung cancer that has spread, or metastasized, may have benefits for patients with metastatic brain cancers, suggests a new review and analysis led by researchers at St.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Lung transplant patients face elevated lung cancer risk
In an American Journal of Transplantation study, lung cancer risk was increased after lung transplantation, especially in the native (non-transplanted) lung of single lung transplant recipients.

Proposed cancer treatment may boost lung cancer stem cells, study warns
Epigenetic therapies -- targeting enzymes that alter what genes are turned on or off in a cell -- are of growing interest in the cancer field as a way of making a cancer less aggressive or less malignant.

Are you at risk for lung cancer?
This question isn't only for people who've smoked a lot.

Read More: Lung Cancer News and Lung Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.